Kenya has reached a historic milestone with the arrival of 21000 doses of Lenacapavir, a twice-yearly injectable HIV prevention drug with rollout starting in March 2026 across 15 priority counties. The drug offering six months of protection for high risk HIV negative individuals, will be provided free in public facilities. Secured at 7,800 per dose with 37,000 more doses expected by April